Weeks relative to start intervention (T) | Â | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Visits | S | 1 | Â | Â | Â | 2 | Â | Â | Â | 3 | |
Telephone contact | Â | Â | 1 | 2 | 3 | Â | Â | 4 | Â | Â | |
Run-in phase | X-es | X-es | Â | Â | Â | Â | Â | Â | Â | Â | |
Intervention phase | Â | Â | X-es | X-es | X-es | X-es | Â | Â | Â | Â | |
Follow-up phase | Â | Â | Â | Â | Â | Â | X-es | X-es | X-es | X-es | |
Participant characteristics | Psychiatric diagnosis, seasonality, chronotype, sleep apnoea, medical history, current medication, biochemical blood tests, sociodemographic factors | X | X | Â | Â | Â | Â | Â | Â | Â | Â |
Psychometrical measures | Depressive symptoms | Â | X | X | X | X | X | Â | Â | Â | X |
Anxiety symptoms | Â | X | X | X | X | X | Â | Â | Â | X | |
Diabetes-related distress | Â | X | Â | Â | Â | X | Â | Â | Â | X | |
Quality of life, disability | Â | X | Â | Â | Â | X | Â | Â | Â | X | |
Glucometabolic measures | Insulin sensitivity | Â | X | Â | Â | Â | X | Â | Â | Â | Â |
HbA1c level | Â | X | Â | Â | Â | X | Â | Â | Â | X | |
Fasting glucose level | Â | X | Â | Â | Â | X | Â | Â | Â | X | |
Hypoglycaemic events | Â | X | X | X | X | X | Â | Â | Â | X | |
Circadian mediating factors | Diurnal HPA axis activity | Â | X | Â | Â | Â | X | Â | Â | Â | X |
Objective sleep | Â | X | Â | Â | Â | X | Â | Â | Â | X | |
Subjective sleep | Â | X | X | X | X | X | Â | Â | Â | X | |
Other factors | Body weight, body mass index, waist-hip ratio, body composition | Â | X | Â | Â | Â | X | Â | Â | Â | X |
Physical activity | Â | X | Â | Â | Â | X | Â | Â | Â | X | |
Autonomic nervous system function | Â | X | Â | Â | Â | X | Â | Â | Â | X | |
Safety | Adverse effects | Â | X | X | X | X | X | Â | Â | Â | X |
Ophthalmological examination | X | Â | Â | Â | Â | Â | Â | Â | Â | X | |
Compliance | Participant-report compliance | Â | Â | X | X | X | X | Â | Â | Â | Â |
Light meter | Â | X | Â | Â | Â | X | Â | Â | Â | X |